These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1620191)

  • 1. Who is it going to be? Subject selection issues in prenatal drug exposure research.
    Fried PA
    NIDA Res Monogr; 1992; 117():121-36. PubMed ID: 1620191
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of prenatal drug exposure and environmental research issues: the benefits of integrating research within a treatment program.
    Kaltenbach KA; Finnegan LP
    NIDA Res Monogr; 1992; 117():259-70. PubMed ID: 1620201
    [No Abstract]   [Full Text] [Related]  

  • 3. How the environment affects research on prenatal drug exposure: the laboratory and the community.
    Coles CD
    NIDA Res Monogr; 1992; 117():271-92. PubMed ID: 1620202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodological issues in prevention research on drug use and pregnancy.
    Gilchrist LD; Gillmore MR
    NIDA Res Monogr; 1992; 117():1-17. PubMed ID: 1620189
    [No Abstract]   [Full Text] [Related]  

  • 5. Methodological issues in obtaining and managing substance abuse information from prenatal patients.
    Sokol RJ; Ager JW; Martier SS
    NIDA Res Monogr; 1992; 117():80-97. PubMed ID: 1620212
    [No Abstract]   [Full Text] [Related]  

  • 6. Discussion: subject selection, recruitment, and retention in longitudinal studies involving perinatal substance abuse and human immunodeficiency virus infection.
    Bandstra ES
    NIDA Res Monogr; 1992; 117():183-93. PubMed ID: 1620196
    [No Abstract]   [Full Text] [Related]  

  • 7. Discussion: measurement issues in the study of effects of substance abuse in pregnancy.
    Coles CD
    NIDA Res Monogr; 1992; 117():248-58. PubMed ID: 1620200
    [No Abstract]   [Full Text] [Related]  

  • 8. Discussion: dilemmas in research in perinatal addiction--intervention issues.
    Finnegan LP
    NIDA Res Monogr; 1992; 117():344-8. PubMed ID: 1620206
    [No Abstract]   [Full Text] [Related]  

  • 9. Subject recruitment and retention for longitudinal research: practical considerations for a nonintervention model.
    Streissguth AP; Guinta CT
    NIDA Res Monogr; 1992; 117():137-54. PubMed ID: 1620192
    [No Abstract]   [Full Text] [Related]  

  • 10. Mandatory reporting of child abuse and research on the effects of prenatal drug exposure.
    Besharov DJ
    NIDA Res Monogr; 1992; 117():366-84. PubMed ID: 1620208
    [No Abstract]   [Full Text] [Related]  

  • 11. Perinatal substance abuse and AIDS: subject selection, recruitment, and retention.
    Rich KC
    NIDA Res Monogr; 1992; 117():166-82. PubMed ID: 1620194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction to the Perinatal-20 treatment research demonstration program.
    Rahdert ER
    NIDA Res Monogr; 1996; 166():1-5. PubMed ID: 8818161
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of biologic markers in epidemiologic studies of prenatal drug exposure: issues in study design.
    Bracken MB; Leaderer B; Belanger K
    NIDA Res Monogr; 1992; 117():41-60. PubMed ID: 1620210
    [No Abstract]   [Full Text] [Related]  

  • 14. Measures of pregnant, drug-abusing women for treatment research.
    Selden AM
    NIDA Res Monogr; 1992; 117():194-211. PubMed ID: 1620197
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessing acute and long-term physical effects of in utero drug exposure on the perinate, infant, and child.
    Bandstra ES
    NIDA Res Monogr; 1992; 117():212-27. PubMed ID: 1620198
    [No Abstract]   [Full Text] [Related]  

  • 16. Discussion: research environment and use of multicenter studies in perinatal substance abuse research.
    Rich KC
    NIDA Res Monogr; 1992; 117():293-304. PubMed ID: 1620203
    [No Abstract]   [Full Text] [Related]  

  • 17. Alcohol- and drug-dependent pregnant women: laws and public policies that promote and inhibit research and the delivery of services.
    Weber EM
    NIDA Res Monogr; 1992; 117():349-65. PubMed ID: 1620207
    [No Abstract]   [Full Text] [Related]  

  • 18. Maternal and fetal effects from substance use.
    Rayburn WF
    Clin Perinatol; 2007 Dec; 34(4):559-71, vi. PubMed ID: 18063105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocaine effects on pregnancy and infant outcome: do we really know how bad it is?
    Dungy-Poythress LJ
    J Assoc Acad Minor Phys; 1995; 6(1):46-50. PubMed ID: 7858377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient pathological cardiotocography secondary to maternal drug abuse.
    Elkington NM; Mills M; Soothill P
    J Obstet Gynaecol; 2004 Feb; 24(2):182-3. PubMed ID: 14766466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.